Lotus Pharm vs HeXun Biosciences: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and HeXun Biosciences (6986) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ HeXun Biosciences

0%+226%-60%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYHeXun BiosciencesYoY
Oct 2026NT$2.13 billion-22.5%NT$10.6 million-59.8%
Sep 2026NT$2.77 billion+128.0%NT$16.7 million-22.7%
Aug 2026NT$2.11 billion+81.7%NT$21.4 million+4.8%
Jul 2026NT$2.49 billion+3.9%NT$15.3 million+5.8%
Jun 2026NT$3.4 billion+225.5%NT$30.4 million+13.4%
May 2026NT$2.32 billion+105.8%NT$46.8 million+10.1%
Apr 2026NT$3.09 billion+19.9%NT$16.7 million-46.8%
Mar 2026NT$4.35 billion+173.6%NT$38.1 million+80.8%
Feb 2026NT$2.24 billion+131.5%NT$19.1 million+10.9%
Jan 2026NT$2.05 billion-5.5%NT$15.4 million+23.1%
Dec 2025NT$2.44 billion+66.9%NT$33.8 million+5.4%
Nov 2025NT$1.06 billion-0.2%NT$25 million-7.3%
Oct 2025NT$2.75 billion+46.0%NT$26.5 million+0.3%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16